Aileron Therapeutics (NASDAQ:ALRN) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Aileron Therapeutics (ALRN) operate in?

Aileron Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Aileron Therapeutics Stock (NASDAQ: ALRN) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	928.00 / 77.80K
Day Range	- - -
52 Wk Range	1.52 - 7.42
Market Cap	$72.15M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	1.08%
Days to Cover	2.26

Recent News

Aileron Therapeutics' Investigational Drug Shows Encouraging Action In Lung Fibrosis

Aileron Therapeutics' Phase 1b trial shows LTI-03 improved biomarkers and reduced SPD levels, indicating the potential to enhance lung function in IPF patients.

Vandana Singh

Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Avi Kapoor

Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	928.00 / 77.80K
Day Range	- - -
52 Wk Range	1.52 - 7.42
Market Cap	$72.15M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	1.08%
Days to Cover	2.26

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Aileron Therapeutics (ALRN) stock?

You can purchase shares of Aileron Therapeutics (NASDAQ:ALRN) through any online brokerage.

View our list of the best stock brokerages

Who are Aileron Therapeutics (ALRN) competitors?

Other companies in Aileron Therapeutics’s space includes: CytomX Therapeutics (NASDAQ:CTMX), bluebird bio (NASDAQ:BLUE), Cellectar Biosciences (NASDAQ:CLRB), Monopar Therapeutics (NASDAQ:MNPR) and Aligos Therapeutics (NASDAQ:ALGS).

What is the forecast, or price target, for Aileron Therapeutics (ALRN) stock?

Aileron Therapeutics has a consensus price target of $10.00.

What is the current price for Aileron Therapeutics (ALRN)?

The stock price for Aileron Therapeutics (NASDAQ: ALRN) is $3.33 last updated November 14, 2024 at 4:20 AM EST.

Does Aileron Therapeutics (ALRN) pay a dividend?

There are no upcoming dividends for Aileron Therapeutics.

When is Aileron Therapeutics (NASDAQ:ALRN) reporting earnings?

Aileron Therapeutics’s Q3 earnings are confirmed for Tuesday, November 26, 2024.

Is Aileron Therapeutics (ALRN) going to split?

There is no upcoming split for Aileron Therapeutics.

What sector and industry does Aileron Therapeutics (ALRN) operate in?

Aileron Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Aileron Therapeutics

Aileron Therapeutics (ALRN) Forecast